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Introduction
Dealing with intensive animal production sys-
tems differs from more undeveloped livestock
productions among others in the composition of
diseases and the lower productivity due to in-
fectious diseases. However, the increase in pro-
ductivity and the demand for additional prof-
itability is not only achieved by improved
breeding stock and herd health programmes but
is also supplied by strategic use of medication
i.e. mainly antibiotics. Medication is no longer
regarded as a therapeutic substance but more
like a necessary mean to achieve maximal
growth in inferior production facilities and is
considered to be a normal part of all intensive
animal production systems. 
The negative consequences of using antimicro-
bials are numerous. Antimicrobials affect the
ability of early detection of exotic diseases. The
epidemic of classical swine fever (CSF) in the
Netherlands remained undetected for several
weeks due to the liberal use of antimicrobials
for symptomatic treatment of sows with abor-
tion and undulant fever (Elbers et al. 1999).
This delayed the detection of CSF and thereby
enhanced the magnitude of the epidemic.
The increasing problems with resistant bacteria
in all animal productions and in humans are
supported by a number of reports (Anon. DAN-
MAP 1997-2000). Special attention is given to
the risk for transmitting food-borne (multi-) re-
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sistant zoonotic agents to humans due to failure
in antibiotic treatment resulting in lower cure
rates or higher case fatality rates.
In 1995 DANMAP, the Danish Integrated An-
timicrobial Resistance Monitoring and Re-
search Programme, was initiated. The objective
of the programme was to monitor the occur-
rence of antimicrobial resistance among bacte-
ria isolated from production animals, food and
humans as well as the consumption of antimi-
crobials. The results are registered in a database
and will form the scientifically based prudent
use of antimicrobials – may it be growth pro-
moters as well as for therapeutic use of antimi-
crobials to production animals.
Several factors are important for the route of
administration, the threshold for initiating treat-
ment and selection of animals for medication.
The majority of these factors are fixed by the
farmer and strongly influenced by the output
profile of the species concerned. Dairy cows
with daily output and an inevitable withdrawal
period for the milk after treatment are medi-
cated individually by parenteral, uterine or
mammary dosing. Species having a single life
production – e.g. pork, beef or poultry – are
more prone to orally medication in whole
groups or herds irrespective of the individual
animal's health status.
Before 1995 the Danish consumption of an-
timicrobials was regulated only by means of le-
gal requirements for veterinary prescription of
the product. Due to a significant rise in the con-
sumption in the beginning of the nineties the
legislation was intensified and statutory herd
health counselling became mandatory for farm-
ers to initiate therapeutic medication of produc-
tion animals. The legislation differs for the dif-
ferent species, but it was specified that
prophylactic treatment should be banned and
the veterinarian was only allowed to prescribe
antimicrobials for animals in a well-defined in-
cubation period and after personal or laboratory
diagnosing. Furthermore, the use of growth
promoters was banned by the 31st August 1999
in Denmark.
Objective, quantitative information regarding
the usage patterns by animal species, antimi-
crobial class, potency and type of use are all es-
sential elements in an evaluation of the antimi-
crobial exposure. Problems in establishing
associations between the consumption of an-
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Figure 1. Usage of antimicrobials in food animals in Denmark (1986-2000) (Anon. 2000).
timicrobials used for production animals and
the detection of resistant bacteria in humans
were soon identified. Hitherto only the total
consumption was registered and lack of knowl-
edge regarding species, herd and dose was
noted in order to draw conclusions.
Therefore, in May 2000 VETSTAT was initi-
ated in Denmark. This register is based on the
Central Husbandry Register (CHR) and all an-
timicrobial prescriptions are registered on farm
level including details about the veterinary
practice prescribing the antimicrobial as well as
the species, age and date of treated group of an-
imals, and diagnosis.
The use of medication in humans per se is ca-
pable of selecting for resistance in human
pathogens. Nevertheless, the volume of used
medication/antimicrobials in treatment of Dan-
ish production animals goes far beyond the vol-
ume used for human consumption (Anon.
2000). After banning of the use of growth pro-
moters in Denmark an increase in the use of
therapeutic medication was predicted. Never-
theless, the consumption figures for oral medi-
cation from 1999 demonstrated a clear reduc-
tion to 32 tons active substance, succeeded by a
50% increase in 2000 to 50 tons whereas the
use of antimicrobials for parenteral (injection,
mammary and uterine) treatments have re-
mained stable (data not shown). Decline in the
consumption of antimicrobials has only been
registered after implementation of new regula-
tions banning products like the growth promot-
ers in 1999 (Fig. 1).
The mink production is a good example as it is
run in a very simple system due to a highly hi-
erarchical and clustered structure of the whole
production system and the monocyclic nature
of the animal. Results from studies showed that
80% of the variation in the incidence of gastro-
intestinal disorders was associated with the
feed producer (Rattenborg et al. 1999). How-
ever, bacteriological examination of faecal
samples have demonstrated that presence of
haemolytic staphylococci and haemolytic E.
coli was neither associated with presence of
clinical symptoms of diarrhoea nor with in-
creased mortality in the same period (Vulfson et
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Figure 2. Mortality rate in the Danish swine production (Anon. 2001a, 2001b). 
al. 2001). Furthermore, substantial consump-
tion of antimicrobials was correlated to poor
feed quality from one feed producer in the
weaning and growth period in 1999 (Chriél &
Dietz 2000). But, in order to obtain the maxi-
mal growth rate in the weaning and growth pe-
riod mink kits are fed ad libitum. Furthermore,
the composition of the feed is based on test re-
sults in order to achieve the maximum growth
and not taking the health of the animals suffi-
ciently into account. Hence, the capacity of
growth impairs the health of the animals. One
might argue that because mink is not part of the
stable-to-table chain no concerns regarding use
of antimicrobials have to be taken. This ap-
proach is, however, not in accordance with the
public opinion and is to be regarded as an irre-
sponsible attitude to good farm practice. Dan-
ish recommendations are more and more fo-
cused on reducing the consumption of
antimicrobials, not as a goal in itself, but rather
as a tool for optimisation of production facili-
ties and management practices.
Focus on the hazards of resistant bacteria has so
far been aimed at food producing animals. Nev-
ertheless the potential risk of spreading antimi-
crobial-resistant organisms as well as remnants
of medicine etc. to the environment have been
addressed in studies of the spread of manure
and slurry (Andersen & Hald 2001), but free
range animal productions and fur production
takes place in direct contact with the environ-
ment. 
The usage patterns of antimicrobials for injec-
tion used for individual therapy of diseased pro-
duction animals have remained constant over
the last 3 years. The significant increase in con-
sumption of oral medication has not been fol-
lowed by a similarly decreased mortality, e.g. il-
lustrated by the number of rendered animals
(Fig. 2 and 3), or increased number of remarks
on the carcasses from the slaughterhouses.
The increased use of antibiotics from 1999 to
2000 is predominantly for oral medication on a
farm/herd basis an administration primarily
used in the pig production. This type of medi-
cation results first of all in medicating healthy
animals together with diseased animals. Fur-
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Figure 3. The total number of Danish cattle livestock and rendered cattle in the last 50 years. (Anon. 2001a,
2001b).
thermore, the efficiency reports of which the
individual farmer is comparing his own produc-
tion results are all based on the maximum
achievable growth a result that often has been
achieved by use of medication but not corrected
for. The natural limit of body-growth has been
pushed upwards during the last decades. 
As an example Norway (Grave & Rønning
2001) and Sweden (Odensvik 2001) have seen a
decrease in the consumption of antimicrobials
in 2000. Veterinary compliance with national
guidelines on selection and use of drugs is men-
tioned as part of the explanation of the more
prudent use of the products but also improved
preventive measures. However it should be
borne in mind that the agricultural structure is
less intensive and with a significant lower out-
put than the Danish animal production. 
The first detection of an emerging pentadrug-
resistant Salmonella Typhimurium DT104
clone was done in the beginning of the 1990 in
UK (Wall et al. 1994). This clone has now
spread worldwide. Although no overall in-
crease in the incidence of salmonellosis has
been detected this clone accounts for more than
35% of the cases in US (Tauxe 1999). Despite
the fact that use of antimicrobials is not indi-
cated in treatment of human salmonellosis it is
often prescribed. The treatment will affect the
normal intestinal flora and thereby facilitate the
selection of resistant bacteria. Epidemiological
studies have shown that the only significant risk
factor for human DT104-outbreaks was use of
antibiotics prior to the outbreak (Holmberg et
al. 1984).
In 1996 the first outbreaks of DT104 were diag-
nosed in 4 Danish herds. All 4 pig herds were
stamped out and the 3 cattle herds were closed
till no DT104 bacteria were shed and hence de-
clared free. This policy was followed till 2000
when it was replaced by special measures taken
at the slaughter process due to a significant rise
in the annual incidence (Fig. 4). If a similar pro-
cess is involved in the outbreaks of DT104 in
animal production as observed in humans, the
widespread use of antimicrobials and circula-
tion of slurry to the near-by environment may
be contributing significantly to an aggravation
of the problem.
Despite all the efforts taken in public as well as
privately financed research activities and all the
knowledge of correct management of the pro-
duction animals we have still not seen substan-
tial progress in the health and welfare of the an-
imals. Furthermore, it seems that the increasing
number of specialised veterinary and agricul-
tural consultants have not improved the animal
health considerably but only assisted in keeping
up the productivity by means of medication. 
Medication in animal production is facing its
limits and relevant economic alternatives
should be developed. The future strategy must
concentrate on using medication only for clini-
cally diseased animals and not as a strategic
treatment of the whole herd in order to max-
imise growth and camouflage suboptimal pro-
duction systems and/or insufficient manage-
ment. It is in everyone's interest that effective
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Figure 4. The annual incidence of Salmonella ty-
phimurium DT104 in Danish production herds
(Anon. 2000).
antimicrobials remain available for appropriate
use in animals and humans, and the veterinary
profession must continue to play its important
part in helping to ensure this. New guidelines
can act to help to ensure that antimicrobials are
used prudently and responsibly, but it is impor-
tant that the individual veterinarian is aware of
his/her responsibility to ensure that the princi-
ples propounded are effectively applied.
Although the economic benefits of using
medicine may exceed the costs, the public opin-
ion should not accept animal productions based
on routine medication as a prerequisite for sus-
taining adequate welfare and profitable produc-
tion. 
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